Modification of the rate of aging of diisopropylfluorophosphate-inhibited neuropathy target esterase of hen brain

Toxicology Letters

Volumn 95, Issue 2, 1998, Pages 93-101

  Jokanović, Milan ^a   Stepanović, Radica M ^b   Maksimović, Matej ^b   Kosanović, Melita ^c   Stojiljković, Miloš P ^c  

^a ICN Yugoslavia Institute   (Yugoslavia)

^b Institute of Bromatology   (Yugoslavia)

^c UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

Atropine; Organophosphate induced delayed polyneuropathy; Organophosphates; Oximes

Indexed keywords

ACETYLCHOLINESTERASE; APROFENE; ATROPINE; BIS(4 TERT BUTYL 1 PYRIDINIOMETHYL) ETHER; DYFLOS; MEMANTINE; METHYLATROPINE; METHYLSCOPOLAMINE; NEUROTOXIC ESTERASE; OXIME; SCOPOLAMINE; TRIMEDOXIME; UREA;

AGING; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME MODIFICATION; FEMALE; HEN; NONHUMAN; POLYNEUROPATHY; PRIORITY JOURNAL;

ACETYLCHOLINESTERASE; ANIMALS; ATROPINE; BRAIN; CARBOXYLIC ESTER HYDROLASES; CHICKENS; DRUG INTERACTIONS; FEMALE; ISOFLUROPHATE; OXIMES; TRIMEDOXIME;

EID: 0032536756     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(98)00017-4     Document Type: Article

References (23)

1. Aldridge, W.N., 1993. Postscript to the symposium on organophosphorus compounds induced delayed neuropathy. Chem.-Biol. Interact. 87, 463-466.
2. Aldridge, W.N., 1995. Aspects of selectivity and mechanisms in neurotoxicity. In: De Matteis, F., Smith, L.L. (Eds.), Molecular and Cellular Mechanisms in Toxicity. CRC Press, Boca Raton, FL, pp. 3-17.
3. Bismith, C., Inns, R.H., Marrs, T., 1992. Efficacy, toxicity and clinical use of oximes in anticholinesterase poisoning. In: Ballantyne, B., Marrs, T.C. (Eds.), Clinical and Experimental Toxicology of Organophosphates and Carbamates. Butterworth-Heinemann, Oxford, pp. 555-577.
4. Clothier, B., Johnson, M.K., 1979. Rapid aging of neurotoxic esterase after inhibition by diisopropyl phosphorofluoridate. Biochem. J. 177, 549-558.
5. Johnson, M.K., 1974. The primary biochemical lesion leading to the delayed neurotoxic effects of some organophosphorus esters. J. Neurochem. 23, 785-789.
6. Johnson, M.K., 1982. The target for initiation of delayed neurotoxicity by organophosphorus esters: Biochemical studies and toxicological applications. Rev. Biochem. Toxicol. 4, 141-212.
7. Johnson, M.K., Vilanova, E., Read, D.J., 1991. Anomalous biochemical responses in tests of the delayed neuropathic potential of methamidophos (O,S-dimethyl phosphorothioamidate), its resolved isomers and of some higher O-alkyl homologues. Arch. Toxicol. 65, 618-624.
8. Jokanović, M., Johnson, M.K., 1993. Interactions in vitro of some organophosphoramidates with neuropathy target esterase and acetylcholinesterase of hen brain. J. Biochem. Toxicol. 8, 19-31.
9. Kuhnen, H., Schrichten, A., Schoene, K., 1985. Influence of atropine upon ageing and reactivation of soman inhibited acetylcholinesterase from human erythrocytes. Arzneim. Forsch./Drug Res. 35, 1454-1456.
10. Lotti, M., 1992. The pathogenesis of organophosphate polyneuropathy. Crit. Rev. Toxicol. 21, 465-487.
11. Lotti, M., Caroldi, S., Capodicasa, E., Moretto, A., 1991. Promotion of organophosphate-induced delayed polyneuropathy by phenylmethanesulfonyl fluoride. Toxicol. Appl. Pharmacol. 108, 234-241.
12. Lotti, M., Moretto, A., Capodicasa, E., Bertolazzi, M., Peraica, M., Scapellato, M.L., 1993. Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy. Toxicol. Appl. Pharmacol. 122, 165-171.
13. Meredith, C., Johnson, M.K., 1988. Neuropathy target esterase: rates of turnover in vivo following covalent inhibition with phenyl di-pentyl phosphinate. J. Neurochem. 51, 1097-1101.
14. Milatović, D., Johnson, M.K., 1993. Reactivation of phosphorodiamidated acetylcholinesterase (AChE) and neuropathy target esterase (NTE) by treatment of inhibited enzyme with potassium fluoride (KF). Chem.-Biol. Interact. 87, 425-430.
15. Pope, C.N., Padilla, S., 1990. Potentiation of organophosphorus-induced delayed neurotoxicity by phenylmethylsulfonyl fluoride. J. Toxicol. Environ. Health 31, 261-273.
16. Radić, Z., Reiner, E., 1986. Effects of atropine on esterases from human blood and pig liver. Acta Pharm. Jugosl. 36, 1-7.
17. Richardson, R.J., 1992. Interactions of organophosphorus compounds with neurotoxic esterase. In: Chambers, J.E., Levi, P.E. (Eds.), Organophosphates: Chemistry, Fate, and Effects. Academic Press, San Diego, pp. 299-323.
18. Richardson, R.J., 1995. Assessment of the neurotoxic potential of chlorpyrifos relative to other organophosphorus compounds: A critical review of the literature. J. Toxicol. Environ. Health 44, 135-165.
19. Schoene, K., 1978. Aging of soman-inhibited acetylcholinesterase: inhibitors and accelerators. Biochim. Biophys. Acta 525, 468-471.
20. Schoene, K., Steinhanses, J., Oldiges, H., 1976. Protective activity of pyridinium salts against soman poisoning in vivo and in vitro. Biochem. Pharmacol. 25, 1955-1958.
21. Stepanović, R.M., Jokanović, M., 1995. Diacetylmonoxime as reactivator of phosphorylated neuropathy target esterase. Arch. Toxicol. Kinet. Xenobiot. Metab. 3, 413-416.
22. Stepanović, R.M., Jokanović, M., Maksimović, M., Bošković, B., Ugrešić, N., 1997. Atropine and oxime TMB-4 improve the clinical signs of organophosphate-induced delayed polyneuropathy in hens. Arch. Toxicol. Kinet. Xenobiot. Metab. 5, 355-358.
23. Van Dongen, C.J., Eskamp, R.M., De Jong, L.P.A., 1987. Influence of atropine upon reactivation and ageing of rat and human erythrocyte acetylcholinesterase inhibited by soman. Biochem. Pharmacol. 36, 1167-1169.